REQUIRED DOSE OF CHOLECALCIFEROL IN THE MANAGEMENT OF VITAMIN D DEFICIENCY AND INSUFFICIENCY IN POSTMENOPAUSAL WOMEN

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504664-42-02

Acronym

IP-VITD

Enrollment

Registered

2023-06-27

Start date

2023-07-03

Completion date

Unknown

Last updated

2023-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POSTMENOPAUSAL WOMEN

Brief summary

To evaluate the efficacy of cholecalciferol, serum vitamin D titration will be performed at the initial view, view 3 and final visit.

Detailed description

Vitamin D levels will be evaluated in the four groups to see if with 1000 IU normal levels are maintained. The patients' satisfaction with the treatment will be evaluated.

Interventions

DRUGLundeos 20.000 UI cápsulas blandas

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of cholecalciferol, serum vitamin D titration will be performed at the initial view, view 3 and final visit.	—

Secondary

Measure	Time frame
Vitamin D levels will be evaluated in the four groups to see if with 1000 IU normal levels are maintained. The patients' satisfaction with the treatment will be evaluated.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026